- FROM THE ANALYST'S COUCH
- Clarification 09 September 2019
The global pipeline of cell therapies for cancer
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 18, 821-822 (2019)
doi: https://doi.org/10.1038/d41573-019-00090-z
Updates & Corrections
-
Clarification 09 September 2019: In addition to the trials of agents included in Figure 1, there is an ongoing phase III trial of tumour-infiltrating lymphocytes in patients with melanoma sponsored by The Netherlands Cancer Institute (NCT02278887), which is included in Supplementary Figure 4.
Supplementary Information
Competing Interests
The authors declare no competing interests.